Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins

N. S. Taylor, J. G. Bartlett

Research output: Contribution to journalArticlepeer-review

Abstract

Cholestyramine and colestipol were tested for binding of Clostridium difficile cytotoxin with the use of batch absorption and column chromatography. The toxin was bound by both resins and could be eluted from cholestyramine with either an ionic or a pH gradient. Vancomycin bound to cholestyramine more strongly than to colestipol. Cholestyramine and vancomycin were also tested for therapeutic efficacy in the hamster model of clindamycin-induced cecitis. Both compounds delayed death and reduced levels of cytotoxin in stool; these effects were greatest for vancomycin. Use of the two compounds in combination reduced concentrations of biologically active vancomycin in stool, but the levels still exceeded the minimum inhibitory concentration for C. difficile. These data suggest that the therapeutic benefit of cholestyramine in some patients with antibiotic-associated pseudomembranous colitis is due to its binding of the C. difficile cytotoxin. Since anion-exchange resins also bind vancomycin, caution is necessary if resins are used concurrently with vancomycin for therapy.

Original languageEnglish (US)
Pages (from-to)92-97
Number of pages6
JournalJournal of Infectious Diseases
Volume141
Issue number1
DOIs
StatePublished - Jan 1 1980
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins'. Together they form a unique fingerprint.

Cite this